Table 6.
Published Studies Examined Salivary Gland Dysfunction by Salivary Gland
| Study | No. of patients | Dose range of RAI (GBq) | Follow-up duration | Salivary gland dysfunctiona | Occurrence of xerostomia |
|---|---|---|---|---|---|
| Malpani et al. (6)b | 33 | 1.4–38.7 | 16 months | 73% | 36% |
| Solans et al. (10) | 48 | 0.9–3.7 | 3 years | 19% | 35% |
| 26 | 7.4–11.1 | 3 years | 35% | 31% | |
| Raza et al. (15)b | 50 | 1.4–≥11.1 | 6 months | 46% | 52% |
| Caglar et al. (16) | 34 | 3.7–5.5 | 20 months | 65% | 35% |
a
Patient-based analysis.
b
Include patients with multiple RAI therapies.
RAI, radioactive iodine.